Trump Has ‘Small,’ ‘Distant Link’ To Sanofi, French Drugmaker Of Hydroxychloroquine

(Updated: 12:55 p.m. EDT, April 7, 2020) Topline: President Trump—increasingly a booster of hydroxychloroquine as a potential treatment for coronavirus—has a “small personal financial interest” in Sanofi, a French drugmaker that produces a brand-name version of the drug—though it’s a tiny investment …